P35475 (IDUA_HUMAN) Homo sapiens (Human)
Alpha-L-iduronidase UniProtKBInterProSTRINGInteractive Modelling
653 aa; Sequence (Fasta) ; (Isoform 2; )
No models could be built to increase the coverage beyond existing experimental structures for this target sequence.
Sequence Features
| 182 | Proton donor | ||
| 299 | Nucleophile | ||
| 18 | L -> P (in MPS1S; dbSNP:rs794726878) VAR_072367 dbSNP | ||
| 33 | H -> Q (in dbSNP:rs10794537) VAR_003350 dbSNP | ||
| 51 | G -> D (in MPS1H; dbSNP:rs794726877) VAR_003351 dbSNP | ||
| 75 | A -> T (in MPS1H; dbSNP:rs758452450) VAR_003352 dbSNP | ||
| 76 | Y -> C (in MPS1S; dbSNP:rs780165694) VAR_066215 dbSNP | ||
| 79 | A -> V (in MPS1H/S; reduction of activity and protein levels; dbSNP:rs747981483) VAR_020975 dbSNP | ||
| 82 | H -> P (in MPS1H/S; dbSNP:rs794727239) VAR_003353 dbSNP | ||
| 82 | H -> Q (reduction of protein levels; dbSNP:rs148775298) VAR_020976 dbSNP | ||
| 84 | G -> R (in MPS1H/S) VAR_066216 | ||
| 89 | R -> Q (in MPS1S; dbSNP:rs121965029) VAR_003354 dbSNP | ||
| 89 | R -> W (in MPS1S; dbSNP:rs754966840) VAR_003355 dbSNP | ||
| 103 | T -> P (in MPS1H; uncertain pathological role) VAR_066217 | ||
| 105 | R -> Q (in dbSNP:rs3755955) VAR_003356 dbSNP | ||
| 116 | G -> R (in dbSNP:rs148946496) VAR_003357 dbSNP | ||
| 133 | M -> I (in MPS1H; dbSNP:rs558683362) VAR_020977 dbSNP | ||
| 178 | E -> K (in MPS1H/S; dbSNP:rs992336192) VAR_066218 dbSNP | ||
| 182 | E -> K (in MPS1H; dbSNP:rs754154200) VAR_020978 dbSNP | ||
| 188 | F -> L (in MPS1H/S; associated with R-423) VAR_066219 | ||
| 208 | G -> D (in MPS1H; dbSNP:rs1430681871) VAR_020979 dbSNP | ||
| 218 | L -> P (in MPS1H; dbSNP:rs869025584) VAR_003358 dbSNP | ||
| 219 | G -> E (in MPS1S; dbSNP:rs1230234600) VAR_066220 dbSNP | ||
| 238 | L -> Q (in MPS1H/S; dbSNP:rs148789453) VAR_020980 dbSNP | ||
| 260 | S -> F (in MPS1H/S) VAR_020981 | ||
| 265 | G -> R (in MPS1H/S; dbSNP:rs369090960) VAR_066221 dbSNP | ||
| 276 | E -> K (in MPS1H/S and MPS1S) VAR_066222 | ||
| 279 | V -> A VAR_003359 | ||
| 300 | A -> T (in IDUA pseudodeficiency; dbSNP:rs121965030) VAR_017435 dbSNP | ||
| 306 | W -> L (in MPS1S) VAR_066223 | ||
| 315 | D -> Y (in MPS1H; loss of function; undetectable enzyme activity) VAR_003360 | ||
| 327 | A -> P (in MPS1H; MPS1H/S; dbSNP:rs199801029) VAR_003361 dbSNP | ||
| 346 | L -> R (in MPS1H/S; 0.4% of normal activity; dbSNP:rs121965033) VAR_017436 dbSNP | ||
| 348 | N -> K (in MPS1S; dbSNP:rs746766617) VAR_066224 dbSNP | ||
| 349 | D -> N (in MPS1H; dbSNP:rs368454909) VAR_003362 dbSNP | ||
| 349 | D -> Y (in MPS1H) VAR_020982 | ||
| 350 | N -> I (in MPS1S) VAR_020983 | ||
| 361 | A -> T (in dbSNP:rs6831280) VAR_003364 dbSNP | ||
| 363 | R -> C (in MPS1H/S; loss of activity; dbSNP:rs750496798) VAR_020984 dbSNP | ||
| 366 | T -> P (in MPS1H; dbSNP:rs121965024) VAR_003365 dbSNP | ||
| 380 | Q -> R (in MPS1H/S and MPS1S; dbSNP:rs762903007) VAR_003366 dbSNP | ||
| 383 | R -> H (in MPS1S; 2-3% of normal activity; dbSNP:rs754949360) VAR_003367 dbSNP | ||
| 385 | P -> R (in MPS1H; dbSNP:rs1553917309) VAR_066225 dbSNP | ||
| 388 | T -> R (in MPS1H; dbSNP:rs794727896) VAR_003368 dbSNP | ||
| 396 | L -> LALL (in MPS1H) VAR_003369 | ||
| 396 | L -> P (in MPS1H/S) VAR_066226 | ||
| 409 | G -> R (in MPS1H; dbSNP:rs11934801) VAR_003370 dbSNP | ||
| 423 | S -> R (in MPS1S and MPS1H/S; associated with L-188 in a patient with MPS1H/S; significant reduction of activity and protein levels; dbSNP:rs931627770) VAR_020985 dbSNP | ||
| 436 | A -> P (in MPS1H/S) VAR_066227 | ||
| 445 | Missing (in MPS1S) VAR_003371 | ||
| 449 | H -> N (in dbSNP:rs532731688) VAR_066228 dbSNP | ||
| 454 | V -> I (in dbSNP:rs73066479) VAR_003372 dbSNP | ||
| 489 | R -> P (in MPS1H) VAR_003373 | ||
| 490 | L -> P (in MPS1H/S and MPS1S; dbSNP:rs121965027) VAR_003374 dbSNP | ||
| 492 | R -> P (in MPS1S; dbSNP:rs121965026) VAR_003375 dbSNP | ||
| 496 | P -> L (in MPS1H/S; dbSNP:rs772416503) VAR_003376 dbSNP | ||
| 496 | P -> R (in MPS1H/S; dbSNP:rs772416503) VAR_066229 dbSNP | ||
| 504 | M -> T (in MPS1H/S) VAR_003377 | ||
| 533 | P -> R (in MPS1H and MPS1H/S; in 3% of the MPS1H patients; reduces catalytic activity and protein stability; dbSNP:rs121965021) VAR_003378 dbSNP | ||
| 535 | L -> F (in MPS1H/S) VAR_066230 | ||
| 591 | A -> T (in dbSNP:rs398123257) VAR_066231 dbSNP | ||
| 602 | F -> I (in MPS1H/S; reduction of activity and protein levels) VAR_020986 | ||
| 619 | R -> G (in MPS1H/S; 1.5% of normal activity; dbSNP:rs121965031) VAR_017437 dbSNP | ||
| 620 | V -> F (in MPS1H; loss of function; undetectable enzyme activity) VAR_072368 | ||
| 626 | W -> R (in MPS1H/S; dbSNP:rs1281475543) VAR_003379 dbSNP | ||
| 628 | R -> P (in MPS1H/S; dbSNP:rs200448421) VAR_020987 dbSNP | ||
| 541-577 | |||
| 16-19 | Missing (in MPS1H) VAR_003349 | ||
| 349-350 | Missing (in MPS1H) VAR_003363 | ||
| 30-543 | Glycoside hydrolase, family 39 IPR000514PF01229 |
Sequence Alignments
Experimental structures
| Description | Oligo-state | Ligands | Structure | Range |
|---|---|---|---|---|
| New Irreversible a-l-Iduronidase Inhibitors and Activity-Based Probes | monomer | 1×NAG; 1×H62; 2×NAG; 2×GOL; 1×TLA; 1×CL; | 6i6r | |
| Assess | ||||
| Human alpha-l-iduronidase | monomer | 1×NAG; 1×NAG; 1×NAG; 3×TLA; 1×GOL; 1×PO4; 1×CL; | 3w81 | |
| Assess | ||||
| New Irreversible a-l-Iduronidase Inhibitors and Activity-Based Probes | monomer | 1×NAG; 1×NAG; 1×NAG; 1×H6B; 7×GOL; 1×TLA; 1×CL; | 6i6x | |
| Assess | ||||
| Human alpha-L-iduronidase in complex with iduronic acid | monomer | 1×NAG; 1×NAG; 1×NAG; 1×IDR; 1×PO4; 1×CL; | 3w82 | |
| Assess | ||||
| Human iduronidase apo structure P21 form | monomer | 1×NAG; 3×GOL; 2×NAG; 1×CL; | 4mj4 | |
| Assess | ||||
| Crystal structure of apo-iduronidase in the R3 form | monomer | 1×NAG; 1×NAG; 1×NAG; 1×GOL; 1×CL; | 4mj2 | |
| Assess | ||||
| Crystal structure of human alpha-L-iduronidase in the P212121 form | monomer | 1×NAG; 2×NAG; 6×GOL; 1×CL; 1×SO4; | 4obs | |
| Assess | ||||
| Crystal structure of human alpha-L-iduronidase complex with 2-deoxy-2-fluoro-alpha-L-idopyranosylur… | monomer | 1×NAG; 1×NAG; 1×NAG; 2×GOL; 1×FIF; 1×CL; | 4kh2 | |
| Assess | ||||
| Crystal structure of human alpha-L-iduronidase complex with alpha-L-iduronic acid | monomer | 1×NAG; 1×NAG; 1×NAG; 3×GOL; 1×TLA; 1×IDR; 1×CL; 1×SO4; | 4obr | |
| Assess | ||||
| Crystal structure of human alpha-L-iduronidase complex with [2R,3R,4R,5S]-2-carboxy-3,4,5-trihydrox… | monomer | 1×NAG; 1×NAG; 1×NAG; 1×GOL; 1×IDJ; | 4kgl | |
| Assess | ||||
| Crystal structure of human alpha-L-iduronidase complex with 5-fluoro-alpha-L-idopyranosyluronic aci… | monomer | 1×NAG; 1×NAG; 1×NAG; 2×GOL; 1×IDF; | 4kgj | |
| Assess | ||||
Homology models built on isoform sequence
| Isoform | Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | monomer | 2×TLA; | -2.82 | 3w81.1.A | 90.67 | |
| Assess | ||||||